(VOX) Voxel S.A. - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLVOXEL00014
VOX: Medical, Imaging, Diagnostic, Radiopharmaceuticals, Therapy, IT
Voxel S.A. (WAR:VOX) is a key player in Polands healthcare sector, specializing in diagnostic imaging. Their services include MRI, CT scans, PET scans, teleradiology, ultrasound, X-rays, and neuroradiosurgery. This comprehensive approach positions them as a one-stop solution for advanced diagnostic needs.
Beyond imaging, Voxel has diversified into COVID-19 testing, neurological hospitals, and information systems for healthcare facilities. They also offer clinical tests, enhancing their role in Polands medical landscape. Their production and sale of radiopharmaceuticals add another layer to their service portfolio, showcasing a vertically integrated business model.
Financially, Voxel boasts a market cap of 1286.56M PLN, with a P/E ratio of 14.32 and a forward P/E of 14.62. Their P/B ratio is 4.52, and P/S is 2.94. These metrics indicate a company with stable growth and a strong market position, making it an attractive option for investors seeking exposure to healthcare and biotechnology in Poland.
In conclusion, Voxel S.A. is strategically positioned with a diversified service offering and a robust financial standing, making it a noteworthy consideration for investors and fund managers focused on the biotechnology sector.
Additional Sources for VOX Stock
VOX Stock Overview
| Market Cap in USD | 331m |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| GiC Sub-Industry | Biotechnology |
| IPO / Inception |
VOX Stock Ratings
| Growth 5y | 92.4% |
| Fundamental | 36.7% |
| Dividend | 74.7% |
| Rel. Strength | 75.8 |
| Analysts | - |
| Fair Price Momentum | 188.71 PLN |
| Fair Price DCF | 87.94 PLN |
VOX Dividends
| Dividend Yield 12m | 2.24% |
| Yield on Cost 5y | 12.85% |
| Annual Growth 5y | 25.03% |
| Payout Consistency | 94.5% |
VOX Growth Ratios
| Growth Correlation 3m | 26.2% |
| Growth Correlation 12m | 92.3% |
| Growth Correlation 5y | 84.3% |
| CAGR 5y | 45.77% |
| CAGR/Max DD 5y | 1.24 |
| Sharpe Ratio 12m | -0.13 |
| Alpha | 51.16 |
| Beta | 0.17 |
| Volatility | 31.68% |
| Current Volume | 8.5k |
| Average Volume 20d | 4.2k |
As of March 29, 2025, the stock is trading at PLN 142.00 with a total of 8,506 shares traded.
Over the past week, the price has changed by +2.90%, over one month by -0.35%, over three months by +12.70% and over the past year by +56.61%.
Partly, yes. Based on ValueRay Fundamental Analyses, Voxel S.A. (WAR:VOX) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.65 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VOX as of March 2025 is 188.71. This means that VOX is currently undervalued and has a potential upside of +32.89% (Margin of Safety).
Voxel S.A. has no consensus analysts rating.
According to ValueRays Forecast Model, VOX Voxel S.A. will be worth about 203.9 in March 2026. The stock is currently trading at 142.00. This means that the stock has a potential upside of +43.59%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 94.3 | -33.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 203.9 | 43.6% |